Ergoteles’s Aehr Test Systems AEHR Stock Holding History

Ergoteles’s Portfolio AEHR Stock Details AEHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-55,490	Closed	-$416K	–	1504
2022 Q2	$416K	Buy	55,490 +43,990	+383%	+$365K	0.01%	921
2022 Q1	$117K	Buy	+11,500	New	+$147K	﹤0.01%	1094

Other funds holding AEHR

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OAM

Oberweis Asset Management Lisle, Illinois $3.39B AUM 105.5% 1-Year Est. Return

AAS

Ameritas Advisory Services Lincoln, Nebraska $2.58B AUM 18.84% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return

Jetstream Capital Brentwood, Tennessee $1.37M AUM

Ergoteles's AEHR Position: Q3 2022 in Review

Ergoteles sold out of Aehr Test Systems (AEHR) in Q3 2022, closing a stake of 55,490 shares — an estimated $416K sold.

Ergoteles first reported a position in AEHR in Q1 2022 and held it in 2 quarters. The position peaked at $416K in Q2 2022. 85 funds tracked by Wall St. Rank hold AEHR as of Q3 2022.

Ergoteles reported no remaining Aehr Test Systems position as of Q3 2022 after selling out during the quarter.
Ergoteles sold 55,490 Aehr Test Systems shares in Q3 2022, an estimated $416K.
Ergoteles first reported a position in Aehr Test Systems in Q1 2022 and held it in 2 quarters.
Ergoteles's Aehr Test Systems position peaked at $416K in Q2 2022.
85 funds tracked by Wall St. Rank held Aehr Test Systems as of Q3 2022.

Based on Ergoteles's 13F filing for Q3 2022, filed 14 Nov 2022.